Stockscreener 앱 받기
1.01
0.00%
0.00
Humacyte Inc 주식(HUMA)의 최신 뉴스
Humacyte (HUMA) Valuation Check As DoD Funding Highlights Battlefield Vascular Repair Potential - Sahm
Aug Levels: Should I invest in Humacyte Inc Equity Warrant before earnings - baoquankhu1.vn
Sell Signal: Can Humacyte Inc deliver consistent EPS growthJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Why Humacyte (HUMA) Is Up 5.1% After New DoD Funding Backs Symvess Trauma Use - simplywall.st
Bond Watch: Can Humacyte Inc deliver consistent EPS growthWeekly Investment Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
HUMA Stock Soars Amid Strategic Business Moves and Financial Outlook - StocksToTrade
HUMA Stock Shows Volatility Amid Speculation and Economic Factors - timothysykes.com
Why Humacyte (HUMA) Is Up 19.6% After New DoD Funding For Biologic Vascular Repair - Yahoo Finance
Humacyte: Positive News For Symvess At Last, But Long-Term Threats Persist (NASDAQ:HUMA) - Seeking Alpha
Humacyte rises on Department of Defense funding for lab-made blood vessels - TradingView
Humacyte (NASDAQ:HUMA) Earns "Buy" Rating from D. Boral Capital - MarketBeat
BTIG reiterates Buy rating on Humacyte stock amid DoD funding news - Investing.com
Humacyte Secures DOD Funding for Bioengineered Blood Vessels - Intellectia AI
HUMA Stock Is Soaring Today – Here’s Everything To Know About The DOD Funding Fueling The Surge - Stocktwits
Humacyte says new U.S. law backs bioengineered vessels (HUMA) - Seeking Alpha
Humacyte announces new U.S. Department of Defense funding for procurement of bioengineered blood vessels - marketscreener.com
Humacyte Says US DoD to Provide Funding for Procurement of Bioengineered Blood Vessels; Shares Rise - marketscreener.com
Humacyte Announces New U.S. Department Of Defense Funding For Procurement Of Bioengineered Blood Vessels - TradingView
Humacyte stock jumps after securing DoD funding for vascular repair tech - Investing.com
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge - Asianet Newsable
Pentagon backs lab-grown blood vessels for wounded troops - Stock Titan
RSI Check: Can Humacyte Inc sustain its profitabilityJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Breakouts Watch: Will Humacyte Inc benefit from rising consumer demandMarket Growth Review & High Win Rate Trade Tips - baoquankhu1.vn
Humacyte set to unveil advances in vascular surgery innovation - Traders Union
Macro Review: Will Humacyte Inc benefit from green energy policiesWeekly Loss Report & Weekly High Return Opportunities - baoquankhu1.vn
Humacyte jumps as DoD issues ECAT listing approval for Symvess - MSN
Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Does Humacyte Inc Equity Warrant have declining or rising EPSBuy Signal & Daily Momentum Trading Reports - baoquankhu1.vn
Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Innovator with a 648% Potential Upside - DirectorsTalk Interviews
Is Humacyte Inc. Equity Warrant in a long term uptrendTrade Risk Assessment & Technical Pattern Based Buy Signals - mfd.ru
Is Humacyte Inc. stock forming a triangle patternBull Run & Advanced Swing Trade Entry Plans - Mfd.ru
Aug Retail: Can Humacyte Inc sustain its profitability2025 Stock Rankings & Safe Entry Point Identification - baoquankhu1.vn
Pharma News: What are the analyst revisions for Air T IncIs Humacyte Inc stock a good investment in YEAR2025 Short Interest & Community Verified Swing Trade Signals - baoquankhu1.vn
Smart Money: What is the target price for Humacyte Inc Equity Warrant stockRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn
Rate Cut: What is the target price for Humacyte Inc Equity Warrant stockNew Guidance & Daily Growth Stock Tips - baoquankhu1.vn
Humacyte (HUMA) Valuation Check As Financing And Israel Filing Plans Lift Investor Interest - Sahm
Aug Swings: Whats the fair value of Humacyte Inc Equity Warrant stockJuly 2025 Volume & Daily Chart Pattern Signals - baoquankhu1.vn
Stop Loss: Will Humacyte Inc benefit from rising consumer demandRisk Management & Technical Confirmation Trade Alerts - baoquankhu1.vn
Humacyte Ends Sale Agreement with Jefferies LLC - MSN
Humacyte, Inc. (NASDAQ:HUMA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Volatility Watch: What are Humacyte Incs technical support levelsTrade Analysis Summary & Community Supported Trade Ideas - baoquankhu1.vn
Humacyte (NASDAQ:HUMA) Given New $10.00 Price Target at Benchmark - MarketBeat
Benchmark lowers Humacyte stock price target to $10 on Israel filing plans - Investing.com India
Humacyte Stock (HUMA) Opinions on Recent Price Surge - Quiver Quantitative
Whale Trades: Whats the fair value of Humacyte Inc stock2025 Price Momentum & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 614% Upside in the Biotech Sector - DirectorsTalk Interviews
Published on: 2026-01-15 08:53:32 - baoquankhu1.vn
Analyst Upgrade: Can Humacyte Inc. stock maintain growth trajectoryTrade Signal Summary & Weekly Momentum Picks - Bộ Nội Vụ
CEO Moves: What catalysts could drive Humacyte Inc. stock higherPortfolio Risk Report & Fast Gain Stock Tips - Bộ Nội Vụ
Humacyte, Inc. (NASDAQ:HUMA): Are Analysts Optimistic? - Yahoo Finance
Quarterly Risk: Does Humacyte Inc Equity Warrant stock benefit from AI growthPortfolio Return Report & Verified Swing Trading Watchlists - baoquankhu1.vn
While institutions invested in Humacyte, Inc. (NASDAQ:HUMA) benefited from last week's 10% gain, retail investors stood to gain the most - simplywall.st
Wall Street analysts see Humacyte, Inc. (HUMA) as a buy: Should you invest? - MSN
Is Humacyte Inc. Equity Warrant stock undervalued vs historical averagesTrail vs Road Selection & quick comparison of popular models - ulpravda.ru
How buybacks impact Humacyte Inc. Equity Warrant stock valueJuly 2025 Gainers & Entry Point Confirmation Alerts - ulpravda.ru
Will Humacyte Inc. Equity Warrant stock gain from lower inflationPortfolio Gains Report & Fast Gaining Stock Reports - ulpravda.ru
Humacyte, Inc. (HUMA) Stock Analysis: Unveiling a Potential 571.55% Upside in the Biotech Sector - DirectorsTalk Interviews
Is Humacyte Inc. Equity Warrant stock a contrarian buyQuarterly Growth Report & Real-Time Volume Spike Alerts - ulpravda.ru
1.12%
0.87%
자본화:
|
볼륨(24시간):